期刊文献+

氯吡格雷联合阿司匹林治疗急性冠脉综合征的临床观察 被引量:4

在线阅读 下载PDF
导出
摘要 目的探讨氯吡格雷(波立维)联合阿司匹林治疗急性冠脉综合征(ACS)的临床效果及安全性。方法选择ACS患者122例随机分为治疗组(64例)和对照组(58例),在常规治疗基础上,治疗组给予氯吡格雷和阿司匹林,对照组单纯给予阿司匹林,均未行介入治疗。观察两组在住院1个月内以及病后1个月~3年意外事件的发生情况,评价其远期疗效及安全性。结果两组均取得良好效果但差异无显著性(P〉0.05)。治疗组远期疗效明显优于对照组(P〈0.05)。结论氯吡格雷联合阿司匹林治疗未行PCI术的ACS患者远期疗效肯定,且优于单用阿司匹林,不良反应少,可积极应用于ACS二级预防。
出处 《右江民族医学院学报》 2006年第5期744-745,共2页 Journal of Youjiang Medical University for Nationalities
  • 相关文献

参考文献9

二级参考文献21

  • 1Ruan C,Haemostasis,1989年,19卷,94页
  • 2Roth M,Niendorf A,Reblin T et al. Detection and quantification of LP (a) in the arterial wall of 107 coronary bypass patients [J]. Arteriosclerosis, 1989,9:579~592.
  • 3Dangas G,Mehron R,Harpel PC et al. LP(a) and inflammation in human coronary atheroma:association with the severity of clinical presentation[J]. JACC,1998,32(7) :2035~2042.
  • 4Cianflone D,Ciccirillo F,Buffon A et al. Comparison of coronany angiographic narrowing in stable angina pectoris,unstable angina pectoris and in acute myocardial infarction[J]. Am J Cardiol, 1995,76 (4): 215~219.
  • 5Ravn HB,Falk E. Histopathology of plague rupture [J]. Cardiol Clin,1999,17(2) :263~270.
  • 6Kim JA,Berliner JA,Nadler JL. Angiotensin Ⅱ increases monocyte biding to endothelial cells [J].Biochem Biophys Res Commune, 1996, 226:862~868.
  • 7Gibbons GH,Dzau VJ. The emerging concept of vascular remodding[J]. New Engl J Med, 1994,330:1431~1438.
  • 8Fuhronan B. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL releptor activity and of a further progressive oxidation of LDL[J]. Free Radic Bilo Med, 1997,23(1): 34~46.
  • 9Berry C,Hamiton CA,Brosnan MJ et al. Investigation into the source of superoxide in human blood vessdls:angiotensin Ⅱ increase superoxide production in human internal mammary arteries[J]. Circulation,2000,101: 2206~2212.
  • 10Liao JK. Endothelium and acute coronary syndromes [J]. Clin Chen,1998,44(8) :1799~1808.

共引文献1460

同被引文献15

  • 1张言镇,赵丽梅,柳林,赵新祥,蔡跃红,吴玉萍.阿司匹林联合氯吡格雷治疗ST段抬高型急性心肌梗死的临床研究[J].潍坊医学院学报,2006,28(2):110-114. 被引量:15
  • 2廖业敏,程芝俏.氯吡格雷、阿司匹林和低分子肝素联用对急性非ST段抬高心肌梗死的疗效分析[J].中国心血管病研究,2007,5(1):33-35. 被引量:15
  • 3王拥军.卒中单元[M].北京:科学技术文献出版社,2004:504-507.
  • 4Kumar S,OConnor A, Despois M,et al. Use of early magnetic resonanceimaging in the diagnosis of occult scaphoid fractures : the CAST Study(Canberra Area Scaphoid Trial) [ J]. N Z Med J, 2005 ,118( 1209 ):U1296.
  • 50Donnell S, Programme I,Research I. Building the Information Societyin Europe : A Pathway Approach to Employment Interventions for Disad-vantaged Groups : 1ST Study Report [ M ] . Information Society Technolo-gies (1ST) Research Programme,European Commission ; Itech Research,2003.
  • 6Wahlgren NG, Ranasinha KW, Rosolacci T,et al. Clomethiazole acutestroke study ( CLASS) : results of a randomized, controlled trial of clome-thiazole versus placebo in 1360 acute stroke patients [ J ]. Stroke, 1999,30(1) :21 -28.
  • 7赵玉文.氯吡格雷联合低分子肝素和阿司匹林治疗老年不稳定型心绞痛的疗效分[J].国医药导报,2009,6(16):50.
  • 8薛翔.阿司匹林联合氯吡格雷治疗急性心肌梗死57例临床观察[J].药物与临床,2010,17(16):67-68.
  • 9Xiao Z,Theroux P.Clop idogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activatidn in patientswith ACS[J].JAm Coil Cardiol, 2004, 43: 1989-1991.
  • 10Xiao Z, Theroux P. Clop idogrel inhibits platelet-leukocyte interac- tions and thrombin receptor agonist peptide-induced platelet activa- tion in patientswith ACS. JAm Coil Cardiol,2004 ,43 :1989-1991.

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部